Research ArticleCancer

Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects

+ See all authors and affiliations

Science Translational Medicine  06 Feb 2013:
Vol. 5, Issue 171, pp. 171ra17
DOI: 10.1126/scitranslmed.3004828

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

  • TIC10 structure
    • Luc Henry, Postdoctoral researcher
    • Other Contributors:

    Dear Editors,

    I write regarding the article 'Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects' by Allen JE et al. originally published in Science Translational Medicine on February 6 2013 (http://stm.sciencemag.org/content/5/171/171ra17.abstract? sid=3a31c5cd-5698-4e53-b38a-3b8d53431043)

    Recently, a reassignment of the s...

    Show More
    Competing Interests: None declared.

Related Content